Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period.
Saved in:
| Title: | Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period. |
|---|---|
| Authors: | Sternberg MR; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Johnson A; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., King J; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Ali AR; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Linde L; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Awofeso AO; Community Health Administration, DC Department of Health, Washington, District of Columbia, United States of America., Baker JS; Division of Population Health, Utah Department of Health and Human Services, Salt Lake City, Utah, United States of America., Bayoumi NS; Communicable Disease Service, New Jersey Department of Health, Trenton, New Jersey, United States of America., Broadway S; Division of Disease Control and Health Protection, Florida Department of Health, Tallahassee, Florida, United States of America., Busen K; Division of Communicable Disease, Michigan Department of Health and Human Services, Lansing, Michigan, United States of America., Chang C; Communicable Disease Service, New York City Department of Health and Mental Hygiene, Long Island City, New York, United States of America., Cheng I; Bureau of Immunization, New York City Department of Health and Mental Hygiene, Long Island City, New York, United States of America., Cima M; Epidemilogy, Arkansas Department of Health, Little Rock, Arkansas, United States of America., Collingwood A; Division of Population Health, Utah Department of Health and Human Services, Salt Lake City, Utah, United States of America., Dorabawila V; Bureau of Surveillance and Data Systems, Division of Epidemiology, Albany, New York State Department of Health, New York, NY, United States of America., Drenzek C; Acute Epidemiology, Georgia Department of Public Health, Atlanta, Georgia, United States of America., Fleischauer A; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Gent A; Division of Disease Control and Health Protection, Florida Department of Health, Tallahassee, Florida, United States of America., Hartley A; Communicable and Environmental Diseases and Emergency Preparedness, Nashville, Tennessee Department of Health, Nashville, Tennessee, United States of America., Hicks L; Bureau of Infectious Disease and Services, Arizona Department of Health Services, Phoenix, Arizona, United States of America., Hoskins M; Communicable Disease, North Carolina Department of Health and Human Services, Raleigh, North Carolina, United States of America., Jara A; Acute Epidemiology, Georgia Department of Public Health, Atlanta, Georgia, United States of America., Jones A; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Khan SI; Communicable Disease Service, New Jersey Department of Health, Trenton, New Jersey, United States of America., Kamal-Ahmed I; Division of Public Health, Nebraska Department of Health and Human Services, Lincoln, Nebraska, United States of America., Kangas S; COVID-19 Data and Surveillance Unit, Wisconsin Department of Health Services, Madison, Wisconsin, United States of America., Kanishka F; Division of Public Health, Nebraska Department of Health and Human Services, Lincoln, Nebraska, United States of America., Kleppinger A; Epidemiology and Infectious Disease Section, Connecticut Department of Public Health, Hartford, Connecticut, United States of America., Kocharian A; COVID-19 Data and Surveillance Unit, Wisconsin Department of Health Services, Madison, Wisconsin, United States of America., León TM; Center for Infectious Diseases, California Department of Public Health, Sacramento, California, United States of America., Link-Gelles R; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Lyons BC; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Masarik J; Community Health Administration, DC Department of Health, Washington, District of Columbia, United States of America., May A; Bureau of Epidemiology and Public Health Informatics, Kansas Department of Health and Environment, Kansas, Missouri, United States of America., McCormick D; Epidemilogy, Arkansas Department of Health, Little Rock, Arkansas, United States of America., Meyer S; Infectious Disease Epidemiology, Prevention and Control Division, Minnesota Department of Health, Saint Paul, Minnesota, United States of America., Milroy L; Disease Epidemiology and Prevention Division, Indiana Department of Health, Indianapolis, Indiana, United States of America., Morris KJ; Infectious Disease Epidemiology, Prevention and Control Division, Minnesota Department of Health, Saint Paul, Minnesota, United States of America., Nelson L; Center for Infectious Diseases, California Department of Public Health, Sacramento, California, United States of America., Omoike E; Division of Communicable Disease, Michigan Department of Health and Human Services, Lansing, Michigan, United States of America., Patel K; Acute Epidemiology, Georgia Department of Public Health, Atlanta, Georgia, United States of America., Pietrowski M; Division of Disease Control, Philadelphia Department of Public Health, Philadelphia, Pennsylvania, United States of America., Pike MA; Disease Control and Public Health Response Division, Colorado Department of Public Health and Environment, Denver, Colorado, United States of America., Pilishvili T; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Peterson Pompa X; Bureau of Infectious Disease and Services, Arizona Department of Health Services, Phoenix, Arizona, United States of America., Powell C; Epidemiology and Infectious Disease Section, Connecticut Department of Public Health, Hartford, Connecticut, United States of America., Praetorius K; CDC Foundation, Atlanta, Georgia, United States of America., Rosenberg E; Bureau of Surveillance and Data Systems, Division of Epidemiology, Albany, New York State Department of Health, New York, NY, United States of America., Schiller A; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Smith-Coronado ML; Disease Control and Public Health Response Division, Colorado Department of Public Health and Environment, Denver, Colorado, United States of America., Stanislawski E; Epidemiology and Response Division, New Mexico Department of Health, Santa Fe, New Mexico, United States of America., Strand K; Division of Public Health, Nebraska Department of Health and Human Services, Lincoln, Nebraska, United States of America., Tilakaratne BP; Community Health Administration, DC Department of Health, Washington, District of Columbia, United States of America., Vest H; Disease Epidemiology and Prevention Division, Indiana Department of Health, Indianapolis, Indiana, United States of America., Wiedeman C; Communicable and Environmental Diseases and Emergency Preparedness, Nashville, Tennessee Department of Health, Nashville, Tennessee, United States of America., Zaldivar A; Bureau of Epidemiology and Public Health Informatics, Kansas Department of Health and Environment, Kansas, Missouri, United States of America., Silk B; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Scobie HM; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. |
| Source: | PloS one [PLoS One] 2023 Sep 20; Vol. 18 (9), pp. e0291678. Date of Electronic Publication: 2023 Sep 20 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0291678 |
